The potential dual effects of sevoflurane on AKT/ GSK3β signaling pathway

Medical Gas Research

Volumn 4, Issue 1, 2014, Pages

  Zhang, Lei ^a,b,c   Zhang, Jie ^a,d   Dong, Yuanlin ^a   Swain, Celeste A ^a   Zhang, Yiying ^a   Xie, Zhongcong ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TONGJI UNIVERSITY   (China)

^c Tongji University   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

AKT GSK3 signaling pathway; Anesthetic; Phosphorylation; Sevoflurane

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 85006223167     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-4-5     Document Type: Article

References (34)

1. DeFrances CJ, Cullen KA, Kozak LJ: National hospital discharge survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 2007, 13:1-209.
2. Rappaport B, Mellon RD, Simone A, Woodcock J: Defining safe use of anesthesia in children. N Engl J Med 2011, 364:1387-1390.
3. Sun L: Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth 2010, 105(Suppl 1):i61-i68.
4. Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO: Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009, 110:796-804.
5. Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO: Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 2011, 128:e1053-e1061.
6. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF: Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003, 23:876-882.
7. Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, Ito M, Imaki J: Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 2009, 110:628-637.
8. Stratmann G, Sall JW, May LD, Bell JS, Magnusson KR, Rau V, Visrodia KH, Alvi RS, Ku B, Lee MT, Dai R: Isoflurane differentially affects neurogenesis and long-term neurocognitive function in 60-day-old and 7-day-old rats. Anesthesiology 2009, 110:834-848.
9. Brambrink AM, Back SA, Riddle A, Gong X, Moravec MD, Dissen GA, Creeley CE, Dikranian KT, Olney JW: Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol 2012, 72:525-535.
10. Brambrink AM, Evers AS, Avidan MS, Farber NB, Smith DJ, Zhang X, Dissen GA, Creeley CE, Olney JW: Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010, 112:834-841.
11. Shen X, Dong Y, Xu Z, Wang H, Miao C, Soriano SG, Sun D, Baxter MG, Zhang Y, Xie Z: Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology 2013, 118:502-515.
12. Phiel CJ, Wilson CA, Lee VM, Klein PS: GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
13. Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K: Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS letters 1998, 436:28-34.
14. Liu F, Iqbal K, Grundke-Iqbal I, Gong CX: Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS letters 2002, 530:209-214.
15. Johnson GV, Hartigan JA: Tau protein in normal and Alzheimer's disease brain: An update. J Alzheim Dis 1999, 1:329-351.
16. Godemann R, Biernat J, Mandelkow E, Mandelkow EM: Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain. FEBS letters 1999, 454:157-164.
17. Cai Z, Zhao Y, Zhao B: Roles of glycogen synthase kinase 3 in Alzheimer's disease. Curr Alzheimer Res 2012, 9:864-879.
18. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA: PKB and the mitochondria: AKTing on apoptosis. Cell Signal 2008, 20:21-30.
19. Yin H, Chao L, Chao J: Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension 2004, 43:109-116.
20. Park SS, Zhao H, Mueller RA, Xu Z: Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 2006, 40:708-716.
21. Song JQ, Teng X, Cai Y, Tang CS, Qi YF: Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 2009, 14:1299-1307.
22. Endo H, Nito C, Kamada H, Nishi T, Chan PH: Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cerebr Blood Flow Metabol 2006, 26:1479-1489.
23. Zhao S, Fu J, Liu X, Wang T, Zhang J, Zhao Y: Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats. Neurol Res 2012, 34:400-407.
24. Dong Y, Zhang G, Zhang B, Moir RD, Xia W, Marcantonio ER, Culley DJ, Crosby G, Tanzi RE, Xie Z: The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol 2009, 66:620-631.
25. Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z: Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology 2010, 112:1404-1416.
26. Zhang Y, Xu Z, Wang H, Dong Y, Shi HN, Culley DJ, Crosby G, Marcantonio ER, Tanzi RE, Xie Z: Anesthetics isoflurane and desflurane differently affect mitochondrial function, learning, and memory. Ann Neurol 2012, 71:687-698.
27. Cross DA, Alessi DR, Vandenheede JR, McDowell HE, Hundal HS, Cohen P: The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 1994, 303(Pt 1):21-26.
28. Sutherland C, Leighton IA, Cohen P: Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993, 296(Pt 1):15-19.
29. Stambolic V, Woodgett JR: Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 1994, 303(Pt 3):701-704.
30. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789.
31. Jope RS, Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29:95-102.
32. Ougolkov AV, Billadeau DD: Targeting GSK-3: A promising approach for cancer therapy? Future Oncol 2006, 2:91-100.
33. Schifilliti D, Grasso G, Conti A, Fodale V: Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS Drugs 2010, 24:893-907.
34. Matchett GA, Allard MW, Martin RD, Zhang JH: Neuroprotective effect of volatile anesthetic agents: molecular mechanisms. Neurol Res 2009, 31:128-134.